FDA and Duke Collaborate to Modernize Clinical Trials

[yoast-breadcrumb]

Under an agreement between the U.S. Food and Drug Administration and Duke University Medical Center, Duke will host a Public-Private Partnership that will include broad representation from government, industry, patient advocacy groups, professional societies, and academia.

PDF icon Download Press Release (58.61 KB)

New CTTI Recommendations Provide Path for More Efficient Clinical Trials Using Clinical Registries

[yoast-breadcrumb]

CTTI Project: Registry Trials

Newly released recommendations from the Clinical Trials Transformation Initiative (CTTI) have the potential to streamline clinical trials by using registry information. Registries are data collection tools typically used to better understand long-term trends in a specific population, such as patients with a particular disease or patients exposed to a certain treatment.

PDF icon Download Press Release (194.86 KB)

Clinical Trials Transformation Initiative Releases Recommendations to Enhance the Feasibility of Developing New Antibacterial Drugs

CTTI Project: ABDD Streamlining HABP/VABP

CTTI’s two new sets recommendations outline innovative approaches to designing clinical trials for HABP/VABP, including early enrollment strategies and the streamlined collection of safety data. CTTI convened multi-stakeholder teams to analyze the challenges associated with HABP/VABP trials and develop the proposed solutions. The feasibility of these new approaches will be tested in an upcoming pilot study, the findings of which are expected to help drive adoption of streamlined practices for antibacterial drug development across the clinical trial enterprise.

PDF icon Download Press Release (73.95 KB)

CTTI Releases Recommendations for Engaging Patients and Sites in Mobile Clinical Trials

[yoast-breadcrumb]

CTTI Project: Preparing a Site

During a public webinar today, the Clinical Trials Transformation Initiative (CTTI) will release new recommendations and resources for engaging patients and research sites when planning and conducting mobile clinical trials. By doing so, sponsors, contract research organizations, and other stakeholders can maximize the opportunities of mobile technologies to advance the development of new medical products.

PDF icon Download Press Release (486.5 KB)

CTTI and FDA Convene Workshop on Including Patient Perspectives in Clinical Trials

[yoast-breadcrumb]

CTTI Project: Patient Group Engagement

The Clinical Trials Transformation Initiative (CTTI) will convene a public workshop, “Enhancing the Incorporation of Patient Perspectives in Clinical Trials," in collaboration with the U.S. Food and Drug Administration (FDA) on Mon., March 18, from 9:00 a.m. to 5:00 p.m. at the Tommy Douglas Conference Center in Silver Spring, Md.

PDF icon Download Press Release (262.53 KB)